Literature DB >> 8687431

Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase.

Y Nagatomo1, K Kitamura, K Kangawa, Y Fujimoto, T Eto.   

Abstract

Proadrenomedullin N-terminal 20 peptide (PAMP) is a novel hypotensive peptide which is processed from an adrenomedullin precursor. PAMP is rapidly cleaved by human neutral endopeptidase (NEP), a protease which plays a key role in the degradation of human atrial natriuretic peptide (ANP). A double reciprocal plot indicated that Km of NEP as a substrate of PAMP was 6.1 microM and V(max) was 3.1 mmol/min/mg of NEP. EDTA, phosphoramidon and thiorphan inhibit the proteolysis of PAMP by NEP. NEP cleaves at least 6 peptide bonds in human PAMP; Arg2-Leu3, Glu8-Phe9, Lys12-Trp13, Lys15-Trp16, Trp16-Ala17 and Ala17-Leu18. The present data suggest that NEP may be involved in the circulation control by degrading PAMP as well as ANP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687431     DOI: 10.1006/bbrc.1996.0930

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Genetic loss of proadrenomedullin N-terminal 20 peptide (PAMP) in mice is compatible with survival.

Authors:  Brooke C Matson; Manyu Li; Claire E Trincot; Elizabeth S Blakeney; Stephanie L Pierce; Kathleen M Caron
Journal:  Peptides       Date:  2018-12-08       Impact factor: 3.750

2.  Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).

Authors:  I B Wilkinson; C M McEniery; K H Bongaerts; H MacCallum; D J Webb; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 3.  Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.

Authors:  Christopher Geven; Matthijs Kox; Peter Pickkers
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 4.  Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.

Authors:  D van Lier; M Kox; P Pickkers
Journal:  J Intern Med       Date:  2020-12-30       Impact factor: 8.989

5.  Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.

Authors:  Carl I Webster; Matthew Burrell; Lise-Lotte Olsson; Susan B Fowler; Sarah Digby; Alan Sandercock; Arjan Snijder; Jan Tebbe; Ulrich Haupts; Joanna Grudzinska; Lutz Jermutus; Christin Andersson
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.